XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2023   339,886,712      
Balance at beginning of period at Dec. 31, 2023 $ 1,256,329 $ 11 $ 2,134,581 $ (65,274) $ (812,989)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued in connection with equity awards (in shares)   3,936,518      
Stock issued in connection with equity awards 23,429   23,429    
Shares withheld related to net share settlement of equity awards (in shares)   (1,397,947)      
Shares withheld related to net share settlement of equity awards (80,144)   (80,144)    
Repurchase of Class A common stock (in shares)   (13,466,397)      
Repurchase of Class A common stock (752,224)   (752,224)    
Stock-based compensation 95,253   95,253    
Other comprehensive loss, net of tax (18,622)     (18,622)  
Net income 236,183       236,183
Balance at end of period (in shares) at Mar. 31, 2024   328,958,886      
Balance at end of period at Mar. 31, 2024 760,204 $ 11 1,420,895 (83,896) (576,806)
Balance at beginning of period (in shares) at Dec. 31, 2023   339,886,712      
Balance at beginning of period at Dec. 31, 2023 1,256,329 $ 11 2,134,581 (65,274) (812,989)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 546,152        
Balance at end of period (in shares) at Jun. 30, 2024   334,168,646      
Balance at end of period at Jun. 30, 2024 814,836 $ 11 1,172,290 (90,628) (266,837)
Balance at beginning of period (in shares) at Mar. 31, 2024   328,958,886      
Balance at beginning of period at Mar. 31, 2024 760,204 $ 11 1,420,895 (83,896) (576,806)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued in connection with equity awards (in shares)   9,435,913      
Stock issued in connection with equity awards 9,377   9,377    
Shares withheld related to net share settlement of equity awards (in shares)   (4,226,153)      
Shares withheld related to net share settlement of equity awards (356,336)   (356,336)    
Stock-based compensation 98,354   98,354    
Other comprehensive loss, net of tax (6,732)     (6,732)  
Net income 309,969       309,969
Balance at end of period (in shares) at Jun. 30, 2024   334,168,646      
Balance at end of period at Jun. 30, 2024 814,836 $ 11 1,172,290 (90,628) (266,837)
Balance at beginning of period (in shares) at Dec. 31, 2024   340,041,739      
Balance at beginning of period at Dec. 31, 2024 1,089,818 $ 11 593,699 (103,096) 599,204
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued in connection with equity awards (in shares)   1,673,751      
Stock issued in connection with equity awards 5,329   5,329    
Shares withheld related to net share settlement of equity awards (in shares)   (422,322)      
Shares withheld related to net share settlement of equity awards (185,667)   (185,667)    
Repurchase of Class A common stock (in shares)   (2,931,609)      
Repurchase of Class A common stock (1,001,670)       (1,001,670)
Stock-based compensation 61,281   61,281    
Other comprehensive loss, net of tax 29,911     29,911  
Net income 576,419       576,419
Balance at end of period (in shares) at Mar. 31, 2025   338,361,559      
Balance at end of period at Mar. 31, 2025 575,421 $ 11 474,642 (73,185) 173,953
Balance at beginning of period (in shares) at Dec. 31, 2024   340,041,739      
Balance at beginning of period at Dec. 31, 2024 1,089,818 $ 11 593,699 (103,096) 599,204
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,395,950        
Balance at end of period (in shares) at Jun. 30, 2025   338,782,503      
Balance at end of period at Jun. 30, 2025 1,167,127 $ 11 448,899 (5,149) 723,366
Balance at beginning of period (in shares) at Mar. 31, 2025   338,361,559      
Balance at beginning of period at Mar. 31, 2025 575,421 $ 11 474,642 (73,185) 173,953
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued in connection with equity awards (in shares)   1,348,598      
Stock issued in connection with equity awards 9,495   9,495    
Shares withheld related to net share settlement of equity awards (in shares)   (195,422)      
Shares withheld related to net share settlement of equity awards (70,983)   (70,983)    
Repurchase of Class A common stock (in shares)   (732,232)      
Repurchase of Class A common stock (270,118)       (270,118)
Stock-based compensation 35,745   35,745    
Other comprehensive loss, net of tax 68,036     68,036  
Net income 819,531       819,531
Balance at end of period (in shares) at Jun. 30, 2025   338,782,503      
Balance at end of period at Jun. 30, 2025 $ 1,167,127 $ 11 $ 448,899 $ (5,149) $ 723,366